HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Xenografts

Cancer Xenografts

Cancer xenografts are a cornerstone of cancer research, involving the transplantation of human tumor cells into immunodeficient mice. This model allows scientists to study tumor growth, progression, and response to treatments in a controlled environment that closely mimics human physiology. By implanting human cancer cells into mice, researchers can observe how tumors develop, metastasize, and interact with the host immune system. Furthermore, xenograft models enable the testing of potential therapies, such as chemotherapy drugs or immunotherapies, providing valuable insights into their efficacy and potential side effects before clinical trials in humans. Despite their limitations, such as the lack of a functional human immune system in the mouse host, cancer xenografts remain a vital tool in advancing our understanding of cancer biology and developing novel therapeutic strategies.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp